Below are listed guidelines that the Society for Endocrinology has written or contributed to, which promote good clinical practice.
December 2011
Society for Endocrinology’s policy on endorsement (pdf) (133kb)
|
This document provides guidance for those considering seeking the Society’s endorsement (revised). |
November 2011
Society for Endocrinology position statement on the use of dopamine agonists in endocrine disorders (pdf) (318kb)
|
This statement (originally issued in February 2009 and recently reviewed) was issued in response to information contained in the MHRA Drug Safety Update (Volume 2, Issue 3 October 2008) |
October 2011
Society for Endocrinology’s information on specialist endocrinology services (pdf) (163kb) |
This document (originally issued in July 2009 and recently reviewed) explains how the wide range of endocrine conditions are best diagnosed and managed by teams of doctors working in a variety of different clinical settings. |
October 2011
Society for Endocrinology information sheet on Primary Hyperparathyroidism (pdf) (166kb) |
This information leaflet produced by the Society for Endocrinology’s Bone and Mineral Special Interest Group provides information on diagnosis and treatment of this condition. |
September 2011
Use of synthetic ACTH (Synacthen) in patients with a history of asthma (pdf) (97kb) |
This statement is issued to coincide with the publication of BNF62 that contains (in section 6.5.1) an amendment to cautions and contraindications in the use of Tetracosactide (Tetracosactrin). |
September 2011
The diagnosis and management of hypothyroidism. (The statement is available on the RCP website)  |
These guidelines, originally issued in November 2008, have now been reviewed and formally re-endorsed by the Society for Endocrinology and the other co-publishing organisations. |
July 2011
Society for Endocrinology UK guidance on the initial evaluation of an infant or an adolescent with a suspected disorder of sex development (pdf) (338kb) |
These Guidelines on a suspected disorder of sex development were produced by the Society for Endocrinology and endorsed by the British Society for Paediatric Endocrinology & Diabetes, the Androgen Insensitivity Syndrome Support Group, the Association for Clinical Biochemistry, the British Society of Paediatric & Adolescent Gynaecology, the British Society of Paediatric Radiology, the CAH Support Group, CLIMB - the National Information Centre for Metabolic Diseases and the Royal College of Nursing. |
July 2011 Endocrine effects of inhaled steroids in respiratory disease (pdf) (123kb) |
This position statement highlights the suppressive effects of inhaled corticosteroids on the endogenous hypothalamo-pituitary-adrenal axis. |
March 2011
Society for Endocrinology information leaflet on adrenal insufficiency (pdf) (621kb) |
This information leaflet produced by the Society for Endocrinology provides an introduction to the causes and symptoms of adrenal insufficiency and the tests used to diagnose this condition. |
December 2010
UK Guidelines Androgens Male (pdf) (189kb) |
These guidelines on the role of androgens in the management of sexual problems in men were produced by the British Society for Sexual Medicine in association with the Society for Endocrinology and others. |
December 2010
UK Guidelines Androgens Female (pdf) (182kb) |
These guidelines on the role of androgens in the management of sexual problems in women were produced by the British Society for Sexual Medicine in association with the Society for Endocrinology and others. |
October 2010
Protocol using oral phenoxybenzamine to prepare patients with catecholamine-secreting phaeochromocytoma and paraganglioma for surgery (PDF) (kb) |
Suggestion of an alternative whilst supplies of the intravenous compound are being restored. |
March 2010
Information sheet on the management of hypoparathyroidism (copies can be downloaded from the Hypoparathyroidism UK website ) |
An information sheet that the Society for Endocrinology produced in collaboration with Hypoparathyroidism UK to help those who have been diagnosed with hypoparathyroidism manage their health. |
August 2009
Swine flu information sheet for patients taking hydrocortisone |
This advice has been prepared for patients that need regular replacement hydrocortisone therapy as a result of pituitary or adrenal (Addison’s disease) failure. |
February 2009
Society for Endocrinology position statement on the use of dopamine agonists in endocrine disorders (PDF) (kb) |
This statement has been issued in response to the information contained in the MHRA Drug Safety Update (Volume 2, Issue 3 October 2008). |